Correlation Between Cingulate and Senti Biosciences
Can any of the company-specific risk be diversified away by investing in both Cingulate and Senti Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate and Senti Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate and Senti Biosciences, you can compare the effects of market volatilities on Cingulate and Senti Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate with a short position of Senti Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate and Senti Biosciences.
Diversification Opportunities for Cingulate and Senti Biosciences
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cingulate and Senti is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and Senti Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Senti Biosciences and Cingulate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate are associated (or correlated) with Senti Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Senti Biosciences has no effect on the direction of Cingulate i.e., Cingulate and Senti Biosciences go up and down completely randomly.
Pair Corralation between Cingulate and Senti Biosciences
Given the investment horizon of 90 days Cingulate is expected to generate 4.19 times less return on investment than Senti Biosciences. But when comparing it to its historical volatility, Cingulate is 1.09 times less risky than Senti Biosciences. It trades about 0.01 of its potential returns per unit of risk. Senti Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 500.00 in Senti Biosciences on November 9, 2024 and sell it today you would lose (67.00) from holding Senti Biosciences or give up 13.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cingulate vs. Senti Biosciences
Performance |
| Timeline |
| Cingulate |
| Senti Biosciences |
Cingulate and Senti Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate and Senti Biosciences
The main advantage of trading using opposite Cingulate and Senti Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate position performs unexpectedly, Senti Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will offset losses from the drop in Senti Biosciences' long position.| Cingulate vs. SAB Biotherapeutics | Cingulate vs. Senti Biosciences | Cingulate vs. Aerovate Therapeutics | Cingulate vs. Adagene |
| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |